Cite

HARVARD Citation

    Mahdi, H. et al. (2021). Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). JCO precision oncology. p. . [Online]. 
  
Back to record